{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:19:33Z","timestamp":1790399973612,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,18]],"date-time":"2027-03-18T00:00:00Z","timestamp":1805328000000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048417"],"award-info":[{"award-number":["R01DA048417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008635","name":"University of Texas Health Science Center at San Antonio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01DA048417"],"award-info":[{"award-number":["R01DA048417"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"The Welch Foundation","doi-asserted-by":"publisher","award":["AQ-0039"],"award-info":[{"award-number":["AQ-0039"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpet.2026.103837","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:21:55Z","timestamp":1770855715000},"page":"103837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of naloxone, naltrexone, nalmefene, and methocinnamox for preventing and reversing the discriminative stimulus effects of buprenorphine and carfentanil in rats discriminating fentanyl from saline"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2494-2754","authenticated-orcid":false,"given":"Takato","family":"Hiranita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Grisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abram E.","family":"Mijares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-6307","authenticated-orcid":false,"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.103837_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.51856","article-title":"Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the COVID-19 pandemic","volume":"6","author":"Tanz","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jpet.2026.103837_bib2","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1542\/peds.2007-1774","article-title":"Toxicity of buprenorphine overdoses in children","volume":"121","author":"Hayes","year":"2008","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.jpet.2026.103837_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1034\/j.1399-6576.2003.00201.x","article-title":"Serious overdoses involving buprenorphine in Helsinki","volume":"47","author":"Boyd","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"10.1016\/j.jpet.2026.103837_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jsat.2010.01.006","article-title":"Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment","volume":"38","author":"M\u00e9garbane","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)21937-1","article-title":"Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone","volume":"229","author":"Shannon","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-001-0943-8","article-title":"Characterization of the discriminative stimulus effects of buprenorphine in pigeons","volume":"160","author":"Galici","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-3565(25)21704-9","article-title":"Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine","volume":"230","author":"France","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"10.1016\/j.jpet.2026.103837_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"[3H]Alvimopan binding to the micro opioid receptor: comparative binding kinetics of opioid antagonists","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103837_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.123.002032","article-title":"Comparison of the \u03bc-opioid receptor antagonists methocinnamox and naloxone to reverse and prevent the ventilatory depressant effects of fentanyl, carfentanil, 3-methylfentanyl, and heroin in male rats","volume":"391","author":"Hiranita","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.106.107953","article-title":"Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats","volume":"319","author":"Yassen","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jpet.2026.103837_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bph.17376","article-title":"Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the \u03bc-opioid receptor","volume":"182","author":"Alhosan","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2026.103837_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108599","article-title":"Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: differential antagonism by naltrexone","volume":"221","author":"Flynn","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2026.103837_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110601","article-title":"Comparison of ventilatory depression by carfentanil, fentanyl, and heroin, and reversal by opioid receptor antagonists in rats","volume":"279","author":"Flynn","year":"2025","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130050242","article-title":"Discriminative stimulus effects of buprenorphine in the rat","volume":"130","author":"Holtzman","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s002130050035","article-title":"Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids","volume":"148","author":"Zhang","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/jpet.124.002323","article-title":"Gabapentinoids increase the potency of fentanyl and heroin and decrease the potency of naloxone to antagonize fentanyl and heroin in rats discriminating fentanyl","volume":"391","author":"Hiranita","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpet.2026.103837_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103523","article-title":"The calcium channel agonist (\u00b1)-BAY-K-8644 attenuates the ability of gabapentinoids to increase the potency of fentanyl and heroin and decrease the potency of cocaine and d-methamphetamine to elicit discriminative stimulus effects in rats","volume":"392","author":"Hiranita","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.103837_bib18","series-title":"Statistical Methods","first-page":"46","author":"Snedecor","year":"1967"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2026.103837_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"issue":"18","key":"10.1016\/j.jpet.2026.103837_bib20","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0024-3205(01)01553-3","article-title":"Antinociceptive activity of a novel buprenorphine analogue","volume":"70","author":"Lattanzi","year":"2002","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(89)90582-7","article-title":"Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain","volume":"167","author":"Titeler","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.jpet.2026.103837_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0028-3908(88)90141-4","article-title":"Comparative binding of mu and delta selective ligands in whole brain and pons\/medulla homogenates from rat: affinity profiles of fentanyl derivatives","volume":"27","author":"Yeadon","year":"1988","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.jpet.2026.103837_bib23","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00213-018-4974-9","article-title":"Abuse liability of mitragynine assessed with a self-administration procedure in rats","volume":"235","author":"Yue","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0376-8716(98)00112-4","article-title":"Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats","volume":"53","author":"Craft","year":"1999","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.jpet.2026.103837_bib25","first-page":"764","article-title":"Sex differences in discriminative stimulus effects of morphine in the rat","volume":"7","author":"Craft","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jpet.2026.103837_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2019.01.020","article-title":"Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats","volume":"150","author":"Schwienteck","year":"2019","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.jpet.2026.103837_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpain.2005.02.002","article-title":"Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice","volume":"9","author":"K\u00f6gel","year":"2005","journal-title":"Eur J Pain"},{"issue":"18","key":"10.1016\/j.jpet.2026.103837_bib28","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1111\/bph.16084","article-title":"Carfentanil is a \u03b2-arrestin-biased agonist at the \u03bc opioid receptor","volume":"180","author":"Ramos-Gonzalez","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.103837_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130050534","article-title":"In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay","volume":"136","author":"Walker","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.jpet.2026.103837_bib31","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/s41386-020-0698-8","article-title":"Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys","volume":"45","author":"Maguire","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.toxlet.2005.02.002","article-title":"Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat","volume":"157","author":"Megarbane","year":"2005","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bja.2021.10.029","article-title":"Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats","volume":"128","author":"Vodovar","year":"2022","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.jpet.2026.103837_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.taap.2006.09.011","article-title":"Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression","volume":"217","author":"Hreiche","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.jpet.2026.103837_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.toxlet.2009.09.017","article-title":"Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats","volume":"191","author":"Chevillard","year":"2009","journal-title":"Toxicol Lett"},{"issue":"4","key":"10.1016\/j.jpet.2026.103837_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.103837_bib37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)36604-2","article-title":"Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine","volume":"281","author":"Ohtani","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.103837_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.119.260331","article-title":"Methocinnamox produces long-lasting antagonism of the behavioral effects of \u03bc-opioid receptor agonists but not prolonged precipitated withdrawal in rats","volume":"371","author":"Gerak","year":"2019","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:14:17Z","timestamp":1776183257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022356526000352"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103837","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of naloxone, naltrexone, nalmefene, and methocinnamox for preventing and reversing the discriminative stimulus effects of buprenorphine and carfentanil in rats discriminating fentanyl from saline","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.103837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103837"}}